Bohnet H G, Kato K, De Moll H
Institute for Hormone and Fertility Research, Hamburg, West Germany.
Obstet Gynecol. 1988 Jan;71(1):53-5.
To elucidate different mechanisms by which bromocriptine, lisuride, and metergoline may inhibit prolactin (PRL) secretion and lactation in puerperal women, the PRL secretion patterns were examined by means of a stimulation test using an intravenous bolus of metoclopramide. After seven and 14 days of treatment, no significant difference in basal serum PRL levels was observed. However, women subjected to metergoline treatment had significantly higher responses of PRL to metoclopramide as compared with those treated with either bromocriptine or lisuride. Thus, the PRL-lowering mechanism of metergoline appears to be different from those of bromocriptine and lisuride.
为阐明溴隐亭、利舒脲和麦角乙脲抑制产后妇女催乳素(PRL)分泌及泌乳的不同机制,采用静脉推注甲氧氯普胺刺激试验检测PRL分泌模式。治疗7天和14天后,基础血清PRL水平未见显著差异。然而,与接受溴隐亭或利舒脲治疗的妇女相比,接受麦角乙脲治疗的妇女对甲氧氯普胺的PRL反应显著更高。因此,麦角乙脲降低PRL的机制似乎与溴隐亭和利舒脲不同。